相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of Aspirin on Cancer Incidence and Mortality in Older Adults
John J. McNeil et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
AGA Clinical Practice Update on Chemoprevention for Colorectal Neoplasia: Expert Review
Peter S. Liang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Associations of Aspirin and Non-Aspirin Non-Steroidal Anti-Inflammatory Drugs With Colorectal Cancer Mortality After Diagnosis
Jane C. Figueiredo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial
Jeffrey A. Meyerhardt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Non-steroidal anti-inflammatory drugs, polygenic risk score and colorectal cancer risk
Xuechen Chen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial
Hideki Ishikawa et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019
C. Bosetti et al.
ANNALS OF ONCOLOGY (2020)
Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial
John Burn et al.
LANCET (2020)
Association of Aspirin and Nonsteroidal Anti-Inflammatory Drugs With Colorectal Cancer Risk by Molecular Subtypes
Efrat L. Amitay et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Non-aspirin non-steroidal anti-inflammatory drugs in prevention of colorectal cancer in people aged 40 or older: A systematic review and meta-analysis
Tanja Tomic et al.
CANCER EPIDEMIOLOGY (2019)
Perioperative Use of Nonsteroidal Anti-inflammatory Drugs Decreases the Risk of Recurrence of Cancer After Colorectal Resection: A Cohort Study Based on Prospective Data
Anders Schack et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Risks of colorectal neoplasms and cardiovascular thromboembolic events after the combined use of selective COX-2 inhibitors and aspirin with 5-year follow-up: a meta-analysis
P. He et al.
COLORECTAL DISEASE (2019)
Association between Nonsteroidal Anti-Inflammatory Drugs and Colorectal Cancer: A Population-Based Case-Control Study
Chun-Nan Kuo et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)
Influence of Smoking, Body Mass Index, and Other Factors on the Preventive Effect of Nonsteroidal Anti-Inflammatory Drugs on Colorectal Cancer Risk
Xiaoliang Wang et al.
CANCER RESEARCH (2018)
Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden
Nele Brusselaers et al.
BMJ OPEN (2018)
Effect of Aspirin on Disability-free Survival in the Healthy Elderly
J. J. McNeil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly
J. J. McNeil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Intake of dietary fibre and lifetime non-steroidal anti-inflammatory drug (NSAID) use and the incidence of colorectal polyps in a population screened for colorectal cancer
Eileen Shaw et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2017)
Influence of NSAID Use Among Colorectal Cancer Survivors on Cancer Outcomes
Christine C. Johnson et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2017)
Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention
Asad Umar et al.
SEMINARS IN ONCOLOGY (2016)
Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis
Parambir S. Dulai et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis
Parambir S. Dulai et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk A Population-Based, Case-Control Study
Soren Friis et al.
ANNALS OF INTERNAL MEDICINE (2015)
Association of Nonsteroidal Anti-Inflammatory Drugs with Colorectal Cancer by Subgroups in the VITamins and Lifestyle (VITAL) Study
Xiaoliang Wang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Association of Aspirin and NSAID Use With Risk of Colorectal Cancer According to Genetic Variants
Hongmei Nan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch Syndrome
Driss Ait Ouakrim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch Syndrome
Driss Ait Ouakrim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer
Kimmie Ng et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
NSAIDs Inhibit Tumorigenesis, but How?
Evrim Gurpinar et al.
CLINICAL CANCER RESEARCH (2014)
Non-Steroidal Anti-Inflammatory Drugs Use Is Associated with Reduced Risk of Inflammation-Associated Cancers: NIH-AARP Study
Fatma M. Shebl et al.
PLOS ONE (2014)
Aspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status
Reiko Nishihara et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Five-Year Analysis of the Prevention of Colorectal Sporadic Adenomatous Polyps Trial
Nadir Arber et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Nonsteroidal Anti-inflammatory Drug Use and Risk of Adenomatous and Hyperplastic Polyps
Harvey J. Murff et al.
CANCER PREVENTION RESEARCH (2011)
A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Adenomatous Polyposis
John Burn et al.
CANCER PREVENTION RESEARCH (2011)
Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer
Anna E. Coghill et al.
GUT (2011)
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Peter M. Rothwell et al.
LANCET (2011)
Effect of aspirin and NSAIDs on risk and survival from colorectal cancer
Farhat V. N. Din et al.
GUT (2010)
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
Peter M. Rothwell et al.
LANCET (2010)
Malignant colorectal polyps
Luis Bujanda et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
Monica M. Bertagnolli et al.
CANCER PREVENTION RESEARCH (2009)
Aspirin Use and Survival After Diagnosis of Colorectal Cancer
Andrew T. Chan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials
Bernard F. Cole et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: Nested case-control study
Yana Vinogradova et al.
GASTROENTEROLOGY (2007)
Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer
David J. Kerr et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: A systematic review prepared for the US Preventive Services Task Force
Alaa Rostom et al.
ANNALS OF INTERNAL MEDICINE (2007)
A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas
John A. Baron et al.
GASTROENTEROLOGY (2006)
Nonsteroidal anti-inflammatory drugs and subsite-specific colorectal cancer incidence in the Iowa Women's Health Study
Amit Mahipal et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
RS Bresalier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States)
JA Tangrea et al.
CANCER CAUSES & CONTROL (2003)
A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis
RKS Phillips et al.
GUT (2002)
Primary chemoprevention of familial adenomatous polyposis with sulindac
FM Giardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
G Steinbach et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
